Neurona Therapeutics is driven by rigorous scientific discovery and focused on developing breakthrough treatments for neurological disorders.

Neurona Therapeutics is a privately-held, clinical-stage biotherapeutics company focused on discovering and developing allogeneic neural cell therapies to treat chronic diseases of the nervous system. Neurona was founded by leading-edge neuroscientists and stem cell pioneers at the University of California, San Francisco. Based on nearly two decades of research, we believe that specific neural cell lineages have the unique ability to integrate and repair dysregulated neural circuits. We have built a robust regenerative medicine discovery platform and developed proprietary methods to manufacture specific types of fully-differentiated neuronal, glial, and gene-edited cell therapy candidates for targeted delivery into the damaged nervous system. Product manufacturing is performed in Neurona’s cGMP facility. Our motivated and talented team of innovators is working to advance first-in-class cell therapy treatments for patients with significant unmet medical needs.


Creating safe and effective cell therapies for chronic disorders of the nervous system through rigorous science, collaborative innovation, and groundbreaking regenerative technology.


Setting the standard for restorative cell therapies that improve quality of life and revolutionize medical treatment for those living with chronic disorders of the nervous system.

Leadership Team

Neurona is founded by world-class researchers at the forefront of neural stem cell biology. We have built an outstanding team of scientists and experienced drug developers who work tirelessly to advance cell-based medicines.


cory nicholas photo

Cory R. Nicholas, PhD

Co-Founder and Chief Executive Officer

catherine priest photo

Catherine Priest, PhD

Chief Development Officer

gautam banik photo

Gautam Banik, PhD

Chief Technology Officer

james stutz photo

James Stutz

Chief Financial Officer and Chief Business Officer

aj joshi photo

Manher “AJ” Joshi, MD

Chief Medical Officer

Nadia Agopyan photo

Nadia Agopyan, PhD

Senior Vice President of Regulatory Affairs

alessandro bulfone photo

Alessandro Bulfone, MD

Vice President of Operations

sheri madrid photo

Sheri Madrid

Vice President of Clinical Operations and Development

david blum photo

David Blum, MD

Senior Medical Advisor

john hixson photo

John Hixson, MD

Senior Medical Director

sergei shevchuk photo

Sergei Shevchuk, PhD

Senior Director of Quality Assurance and Quality Control

james tanaka photo

James Tanaka

Senior Director of Finance

Board of Directors

Scientific Advisors

Our Investors

alexandria venture logo

columbia university logo

cormorant asset management logo

euclidean capital logo

hartford healthcare logo

ironfire ventures logo

lyfe capital logo

schroders capital logo

sphera funds logo

spur capital logo

column group logo

topspin partners logo

ucb ventures logo

university california logo

viking global investors logo

ysios capital logo